Transforming Growth Factor Beta 1 as a Potential Biomarker in Children With Sickle Cell Disease-Reference-Cited by-同舟云学术

Transforming Growth Factor Beta 1 as a Potential Biomarker in Children With Sickle Cell Disease

Published:2023-03-24 Issue:4 Volume:45 Page:225-226
ISSN:1077-4114
Container-title:Journal of Pediatric Hematology/Oncology
language:en
Short-container-title:

Author:

Ilonze Chibuzo¹,Anderson Michael²,Stubblefield Alex³,McNall-Knapp René⁴,Braly Emily⁴,Journeycake Janna⁴,Sinha Arpan A.⁴^ORCID

Affiliation:

1. Division of Pediatric Hematology Oncology, Department of Pediatrics University of Alabama at Birmingham Birmingham, AL

2. Department of Epidemiology & Biostatistics, University of Oklahoma Health Sciences Center, Oklahoma City, OK

3. Department of Economics, Michigan State University, MI

4. Department of Pediatrics, Jimmy Everest Center Section of Pediatric Hematology Oncology, University of Oklahoma Health Sciences Center, Oklahoma City, OK

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Reference12 articles.

1. Association of homocysteine and inflammatory-related molecules in sickle cell anemia;Vilas-Boas;Hematology,2016

2. Plasma levels of TGF-beta1 in homeostasis of the inflammation in sickle cell disease;Torres Lde;Cytokine,2016

3. Altered levels of pro-inflammatory cytokines in sickle cell disease patients during vaso-occlusive crises and the steady state condition;Keikhaei;Eur Cytokine Netw,2013

4. Associations between TGF-beta1 levels and markers of hemolysis, inflammation, and tissue remodeling in pediatric Sickle cell patients;Santiago;Mediators Inflamm,2021

5. Sickle cell anemia mice develop a unique cardiomyopathy with restrictive physiology;Bakeer;Proc Natl Acad Sci USA,2016